Two conserved domains in PCIF1 mediate interaction with pancreatic transcription factor PDX-1

FEBS Letters

Volumn 580, Issue 28-29, 2006, Pages 6701-6706

  Liu, Aihua ^a   Oliver Krasinski, Jennifer ^a   Stoffers, Doris A ^a  

^a Institute for Diabetes   (United States)

Author keywords

Development; Diabetes; Insulin; Islet; MODY; Pancreas

Indexed keywords

PDX C TERMINUS INTERACTING FACTOR 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PDX 1;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CONTROLLED STUDY; GLUCOSE METABOLISM; INSULINOMA; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN INTERACTION; TRANSACTIVATION;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; CELL NUCLEUS; CONSERVED SEQUENCE; EVOLUTION, MOLECULAR; GLUTAMINE; HELA CELLS; HOMEODOMAIN PROTEINS; HUMANS; LYSINE; MICE; MOLECULAR SEQUENCE DATA; MUTATION; NUCLEAR PROTEINS; PANCREAS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; REPRESSOR PROTEINS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; ZEBRAFISH;

EID: 33751524384     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.11.021     Document Type: Article

References (23)

1. Habener J.F., Kemp D.M., and Thomas M.K. Minireview: transcriptional regulation in pancreatic development. Endocrinology 146 (2005) 1025-1034
2. Wilding L., and Gannon M. The role of pdx1 and HNF6 in proliferation and differentiation of endocrine precursors. Diabetes. Metab. Res. Rev. 20 (2004) 114-123
3. Cockburn B.N., et al. Insulin promoter factor-1 mutations and diabetes in Trinidad: identification of a novel diabetes-associated mutation (E224K) in an Indo-Trinidadian family. J. Clin. Endocrinol. Metab. 89 (2004) 971-978
4. Hani E., Stoffers D., XChevre J., Durand E., Stanojevic V., Dina C., Habener J., and Froguel P. Defective mutations in the insulin promoter factor-1(IPF-1) gene in late-onset type 2 diabetes mellitus. J. Clin. Invest. 104 (1999) R41-R48
5. Weng J., et al. Functional consequences of mutations in the MODY4 gene(IPF1) and coexistence with MODY3 mutations. Diabetologia 44 (2001) 249-258
6. Lu M., Miller C., and Habener J. Functional regions of the homeodomain protein IDX-1 required for transactivation of the rat somatostatin gene. Endocrinology 137 (1996) 2959-2967
7. Peers B., Leonard J., Sharma S., Teitelman G., and Montminy M. Insulin expression in pancreatic islet cells relies on cooperative interactions between the helix loop helix factor E47 and the homeobox factor STF-1. Mol. Endocrinol. 8 (1994) 1798-1806
8. Peshavaria M., Henderson E., Sharma A., Wright C., and Stein R. Functional characterization of the transactivation properties of the PDX-1 homeodomain protein. Mol. Cell Biol. 17 (1997) 3987-3996
9. Shushan E., Cerasi E., and Melloul D. Regulation of the insulin gene by glucose: stimulation of transactivation potency of human PDX-1 N-terminal domain. DNA Cell Biol. 18 (1999) 471-479
10. Mosley A.L., Corbett J.A., and Ozcan S. Glucose regulation of insulin gene expression requires the recruitment of p300 by the beta-cell-specific transcription factor Pdx-1. Mol. Endocrinol. 18 (2004) 2279-2290
11. Mosley A.L., and Ozcan S. Pdx-1 interacts with histone deacetylases Hdac-1 and Hdac-2 on low levels of glucose. J. Biol. Chem. 279 (2004) 54241-54247
12. Liu A., Desai B.M., and Stoffers D.A. Identification of PCIF1, a POZ domain protein that inhibits PDX-1 (MODY4) transcriptional activity. Mol. Cell Biol. 24 (2004) 4372-4383
13. Miller C., McGehee R.J., and Habener J. IDX-1: a new homeodomain transcription factor expressed in rat pancreatic islets and duodenum that transactivates the somatostatin gene. EMBO J. 13 (1994) 1145-1156
14. Stoffers D.A., Stanojevic V., and Habene J.F. Insulin promoter factor-1 gene mutation linked to early-onset type 2 diabetes mellitus directs expression of a dominant negative isoprotein. J. Clin. Invest. 102 (1998) 232-241
15. Milewski W.M., Duguay S.J., Chan S.J., and Steiner D.F. Conservation of PDX-1 structure, function, and expression in zebrafish. Endocrinology 139 (1998) 1440-1449
16. Wong C.W., and Privalsky M.L. Interactions with the POZ Domain Oncoproteins PLZF, PLZF-RARalpha, and BCL-6. JBC 273 (1998) 27695-27702
17. Takahashi I., Kameoka Y., and Hashimoto K. MacroH2A1.2 binds the nuclear protein Spop. Biochim. Biophys. Acta 1591 (2002) 63-68
18. David G., Alland L., Hong S.H., Wong C.W., DePinho R.A., and Dejean A. Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein. Oncogene 16 (1998) 2549-2556
19. Huynh K.D., and Bardwell V.J. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT. Oncogene 17 (1998) 2473-2484
20. Ishizuka T., and Lazar M.A. The nuclear receptor corepressor deacetylase activating domain is essential for repression by thyroid hormone receptor. Mol. Endocrinol. 19 (2005) 1443-1451
21. Nagai Y., Kojima T., Muro Y., Hachiya T., Nishizawa Y., Wakabayashi T., and Hagiwara M. Identification of a novel nuclear speckle-type protein, SPOP. FEBS Lett. 418 (1997) 23-26
22. Lamond A.I., and Spector D.L. Nuclear speckles: a model for nuclear organelles. Nat. Rev. Mol. Cell Biol. 4 (2003) 605-612
23. Kelly K.F., Spring C.M., Otchere A.A., and Daniel J.M. NLS-dependent nuclear localization of p120ctn is necessary to relieve Kaiso-mediated transcriptional repression. J. Cell Sci. (2004) 117